Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Favorable safety and efficacy of ITI-007 against acutely exacerbated schizophrenia

May 8, 2014

NN-8555 demonstrates efficacy and safety in phase II Crohn's disease trial

May 8, 2014

IDH1 gene mutation-specific vaccine developed for treatment of patients with glioma

May 8, 2014

Lysophospholipid LPA2 receptor ligands for radiation injury synthesized

May 8, 2014

First preclinical results for AMA-0428 as treatment for wet AMD

May 8, 2014

BMS presents oral pan-Notch inhibitor for cancer

May 8, 2014

Researchers develop and test novel oral Shigella challenge model

May 8, 2014

Low-dose suvorexant safe and effective in elderly and nonelderly adults with primary insomnia

May 7, 2014

Results of a phase II study of the PsA-TT vaccine in infants with meningococcal disease

May 7, 2014

Cepham develops novel green coffee bean extract for weight management

May 7, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...